Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hypergastrinemia: causes and consequences.

Lori A Orlando1, Lane Lenard, Roy C Orlando

  • 1Duke University Center for Clinical Health Policy and Durham VA, Durham, North Carolina, USA. orlan002@mc.duke.edu

Digestive Diseases and Sciences
|April 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraction of Human Phenotype Ontology (HPO) Concepts from Clinical Notes Utilizing Large Language Models (LLM) with Model Context Protocol (MCP).

medRxiv : the preprint server for health sciences·2026
Same author

Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.

JAMA network open·2026
Same author

Genetic Testing for APOL1 in Adults With Hypertension: The GUARDD-US Randomized Clinical Trial.

JAMA network open·2026
Same author

CYP2D6-Guided Opioid Management and Postoperative Pain Control: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer.

Contemporary clinical trials·2024

Gastrin is a key hormone in digestion and cell growth. Chronic overproduction, or hypergastrinemia, can lead to health issues like Zollinger-Ellison syndrome and concerns with proton pump inhibitor use.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Cell Biology

Background:

  • Gastrin is crucial for gastric acid secretion and epithelial cell growth.
  • Pathological conditions like Zollinger-Ellison syndrome and pernicious anemia involve excessive gastrin.
  • Recent concerns link chronic hypergastrinemia to proton pump inhibitor (PPI) therapy.

Purpose of the Study:

  • To provide a concise overview of chronic hypergastrinemia.
  • To discuss the origins and causes of elevated gastrin levels.
  • To outline the potential health risks associated with chronic hypergastrinemia.

Main Methods:

  • Literature review of gastrin's physiological roles.
  • Analysis of pathological conditions associated with hypergastrinemia.

Related Experiment Videos

  • Evaluation of recent concerns regarding PPIs and gastrin levels.

    • Main Results:

    • Gastrin's dual role in acid secretion and trophic effects is established.
    • Chronic hypergastrinemia can manifest in severe gastrointestinal diseases.
    • Widespread PPI use raises questions about long-term gastrin-related risks.

    Conclusions:

    • Understanding gastrin's function is vital for gastrointestinal health.
    • Chronic hypergastrinemia presents significant pathological potential.
    • Further research is needed to fully assess the risks of long-term hypergastrinemia, especially in the context of PPI therapy.